Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Industry and Commerce	4.24B	3.88B	3.43B	3.41B	4.67B
Pharmaceutical Industry and Commerce Growth	9.41%	12.89%	0.77%	-26.98%	-49.73%
Health Food and Food	437.48M	502.79M	324.58M	184.23M	187.02M
Health Food and Food Growth	-12.99%	54.90%	76.18%	-1.49%	-44.98%
Property Leasing and Sales and Others	510.55M	494.89M	421.95M	560.99M	559.03M
Property Leasing and Sales and Others Growth	3.16%	17.29%	-24.79%	0.35%	-69.36%
Total	5.19B	4.87B	4.18B	4.15B	5.41B
Total Growth	6.47%	16.60%	0.67%	-23.27%	-52.72%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China	5.19B	4.87B	4.18B	4.15B	5.41B
China Growth	6.47%	16.60%	0.67%	-23.27%	-52.49%
Total	5.19B	4.87B	4.18B	4.15B	5.41B
Total Growth	6.47%	16.60%	0.67%	-23.27%	-52.72%

Source: S&P Global Market Intelligence.